API Holdings, the parent company of online pharmacy PharmEasy, announced last week that it would pick up a 66.1 per cent stake in diagnostics firm Thyrocare for Rs 4,546 crore. It is the first unicorn to acquire a listed company.

• HDFC Bank Shares Climb 3% on Strong Q1 Update
• Overnight Stock Market Movements: Key Developments 
• Stocks Under F&O Ban 
• Indian Hume Pipe Soars 9% on Rs 738 Cr Rajasthan Order
• Max Estates Jumps 6% as Q1 Pre-Sales Surges 5x

One of the most extensive consolidations in the domestic health care space, the deal was struck in record time at the Mumbai residence of A Velumani, founder of Thyrocare. The deal is also a milestone for five friends from the Mumbai suburb of Ghatkopar, who called themselves the Ghatkopar Gujju gang and set up PharmEasy in 2015.